AS2541019
CAS No. 2098906-98-8
AS2541019( AS 2541019 )
Catalog No. M13323 CAS No. 2098906-98-8
AS2541019 is a novel potent, selective, orally active PI3Kδ inhibitor with IC50 of 20.1 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAS2541019
-
NoteResearch use only, not for human use.
-
Brief DescriptionAS2541019 is a novel potent, selective, orally active PI3Kδ inhibitor with IC50 of 20.1 nM.
-
DescriptionAS2541019 is a novel potent, selective, orally active PI3Kδ inhibitor with IC50 of 20.1 nM, >100-fold selectivity over other PI3K isoforms; inhibits Akt phosphorylation in human Ramos B cell line with IC50 of 14.3 nM, effectively inhibits anti-IgM stimulated B cell proliferation and human B cell proliferation with IC50 of 4.3 and 3.6 nM, respectively; significantly inhibits both T-dependent and T-independent de novo antibody production in peripheral blood in vivo; significantly prolongs graft survival time by inhibiting xenoreactive antibody production in rat concordant xenotransplant model.
-
In Vitro——
-
In Vivo——
-
SynonymsAS 2541019
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2098906-98-8
-
Formula Weight529.593
-
Molecular FormulaC26H33F2N7O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N[C@H]1CC[C@H](OC2=NC(N3CCOCC3)=NC(N4C(C(F)F)=NC5=CC=CC=C45)=C2)CC1)CN(C)C
-
Chemical NameN-[trans-4-({6-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-2-(morpholin-4-yl)pyrimidin-4-yl}oxy)cyclohexyl]-2-(dimethylamino)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Marui T, et al. Eur J Pharmacol. 2018 Mar 5. pii: S0014-2999(18)30133-X.
molnova catalog
related products
-
SF-1126
SF-1126?is a pan PI3K/BRD4 inhibitor, RGDS-conjugated LY294002 prodrug that exhibits increased solubility and binds to specific integrins.
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
GDC-0941 dimethanesu...
A potent, selective, orally bioavailable inhibitor of class I PI3Ks with IC50 of 3/33/3/75 nM for p110α/β/γ/δ, respectively.
Cart
sales@molnova.com